Dobromir Dobrev

Enhanced Ca2+-Driven Arrhythmias in Female Patients with Atrial Fibrillation: Insights from Computational Modeling

W. Louch, S. Morotti, Xianwei Zhang, 2024, bioRxiv.

Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference

I. V. Van Gelder, M. Rienstra, H. Puererfellner, 2024, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

An inflammation resolution-promoting intervention prevents atrial fibrillation due to left-ventricular dysfunction.

Jiening Xiao, J. Tardif, J. Tanguay, 2023, Cardiovascular research.

The thrombin receptor PAR4 supports visceral adipose tissue inflammation.

A. Fender, S. Kleeschulte, Markus Kamler, 2024, Naunyn-Schmiedeberg's archives of pharmacology.

Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence

A. Semb, G. Savarese, M. Camilli, 2024, European heart journal.

Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation.

J. Heijman, A. Saljic, Dobromir Dobrev, 2024, British journal of pharmacology.

Transient Receptor Potential Canonical-3 Channel–Dependent Fibroblast Regulation in Atrial Fibrillation

J. Tardif, D. V. Van Wagoner, K. Kamiya, 2012, Circulation.

Recent highlights on myocarditis and cardiomyopathies from the International Journal of Cardiology and International Journal of Cardiology: Heart & Vasculature

Nicolina Conti, A. Tedeschi, Enrico Ammirati, 2023, International journal of cardiology. Heart & vasculature.